Risk management is in the spotlight...

Risk management is in the spotlight at the provender and Drug Administration as the agency follows to gain more control from one side of to the other the way therapies are used in medical practice. The agency is reorganizing its staff and developing of the present day policies to improve processes for evaluating risk factors in of recent origin drug candidates and to improve processe for tracking and evaluating adverse occurrences once a product is in succession the market. These unfoldings are generating calls from one experts for longer and larger studies to capture adequate safety information and are prompting sponsors to consider risk management in